A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy

PURPOSE: Some breast cancer survivors report cognitive difficulties greater than 1 year after chemotherapy. Acetylcholinesterase inhibitors (AChEI) may improve cognitive impairment. We conducted a randomized, placebo-controlled, pilot study to assess the feasibility of using the AChEI, donepezil, to...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Cancer Surviv
मुख्य लेखकों: Lawrence, J. A., Griffin, L., Balcueva, E. P., Groteluschen, D. L., Samuel, T. A., Lesser, G. J., Naughton, M. J., Case, L. D., Shaw, E. G., Rapp, S. R.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2015
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4930878/
https://ncbi.nlm.nih.gov/pubmed/26130292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11764-015-0463-x
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन